Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

The Children's National Research Institute

Program for Cell Enhancement and Technologies for Immunotherapy (CETI)

Stat madness

Immunotherapy represents the most exciting recent development in cancer therapy. Children’s National Hospital faculty members are at the forefront in developing molecular and cellular therapeutic approaches to harness the power of the immune system to combat cancer. The researchers are developing novel therapeutic approaches to target cancer cells, with a major emphasis on identifying and generating tools to effectively target cancer antigens that are recognized by either T cell receptors or immunoglobulin. Investigators are also developing new monoclonal antibodies that rejuvenate cancer immunity by stimulating cancer-reactive T-cells. The Cell Enhancement and Technologies for Immunotherapy (CETI) Program consists of two main programmatic areas: targeting pathogens and eliminating cancer.